Literature DB >> 3310871

Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.

J W Hathorn1, M Rubin, P A Pizzo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3310871      PMCID： PMC174854          DOI： 10.1128/AAC.31.7.971

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  54 in total

1.  Infections in cancer patients. Results with gentamicin sulfate therapy.

Authors:  G P Bodey; E Middleman; T Umsawadi; V Rodriguez
Journal:  Cancer       Date:  1972-06       Impact factor: 6.860

2.  Pseudomonas bacteremia in patients with malignant diseases.

Authors:  J P Whitecar; M Luna; G P Bodey
Journal:  Am J Med Sci       Date:  1970-10       Impact factor: 2.378

3.  Carbenicillin therapy for pseudomonas infections.

Authors:  G P Bodey; J P Whitecar; E Middleman; V Rodriguez
Journal:  JAMA       Date:  1971-10-04       Impact factor: 56.272

4.  Factors affecting mortality of gram-negative rod bacteremia.

Authors:  R E Bryant; A F Hood; C E Hood; M G Koenig
Journal:  Arch Intern Med       Date:  1971-01

Review 5.  The use of combinations of antimicrobial drugs.

Authors:  E Jawetz
Journal:  Annu Rev Pharmacol       Date:  1968       Impact factor: 13.820

6.  Antibiotic combinations for infections in neutropenic patients. Evaluaton of carbenicillin plus either cephalothin or kanamycin.

Authors:  E L Middleman; A Watanabe; H Kaizer; G P Bodey
Journal:  Cancer       Date:  1972-08       Impact factor: 6.860

7.  Pharmacology of gentamicin in man.

Authors:  L J Riff; G G Jackson
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

8.  Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.

Authors:  G P Bodey; M Buckley; Y S Sathe; E J Freireich
Journal:  Ann Intern Med       Date:  1966-02       Impact factor: 25.391

9.  Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia.

Authors:  S Schimpff; W Satterlee; V M Young; A Serpick
Journal:  N Engl J Med       Date:  1971-05-13       Impact factor: 91.245

10.  Comparative activity of tobramycin, amikacin, and gentamicin alone and with carbenicillin against Pseudomonas aeruginosa.

Authors:  R M Kluge; H C Standiford; B Tatem; V M Young; W H Greene; S C Schimpff; F M Calia; R B Hornick
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191
View more
  9 in total

1.  A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia.

Authors:  Fausto Rossini; Elisabetta Terruzzi; Luisa Verga; Alessandra Larocca; Sara Marinoni; Isabella Miccolis; Giuseppe Giltri; Manuela Isella; Matteo Parma; Enrico M Pogliani
Journal:  Support Care Cancer       Date:  2004-12-15       Impact factor: 3.603

Review 2.  Methods of minimising the cost of aminoglycoside therapy to hospitals.

Authors:  C A Gentry; K A Rodvold; J S Bertino
Journal:  Pharmacoeconomics       Date:  1993-03       Impact factor: 4.981

3.  Oral ofloxacin therapy of Pseudomonas aeruginosa sepsis in mice after irradiation.

Authors:  I Brook; G D Ledney
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

4.  Fluoroquinolone Prophylaxis Is Highly Effective for the Prevention of Central Line-Associated Bloodstream Infections in Autologous Stem Cell Transplant Patients.

Authors:  Matthew Ziegler; Daniel Landsburg; David Pegues; Warren Bilker; Cheryl Gilmar; Colleen Kucharczuk; Theresa Gorman; Kristen Bink; Amy Moore; Rebecca Fitzpatrick; Edward A Stadtmauer; Patricia Mangan; Kelly Kraus; Jennifer H Han
Journal:  Biol Blood Marrow Transplant       Date:  2018-11-24       Impact factor: 5.742

5.  Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo.

Authors:  R P Darveau; M D Cunningham; C L Seachord; L Cassiano-Clough; W L Cosand; J Blake; C S Watkins
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

6.  Teicoplanin plus ciprofloxacin versus gentamicin plus piperacillin in the treatment of febrile neutropenic patients.

Authors:  S M Kelsey; B Weinhardt; P W Collins; A C Newland
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

7.  Adverse effects of pefloxacin in irradiated C3H/HeN mice: correction with glucan therapy.

Authors:  M L Patchen; I Brook; T B Elliott; W E Jackson
Journal:  Antimicrob Agents Chemother       Date:  1993-09       Impact factor: 5.191

8.  Amikacin and ceftazidime as empirical antibiotic therapy in severely neutropenic patients: analysis of prognostic factors.

Authors:  F Rossini; P Pioltelli; S Mingozzi; R Bregani; F Viganó; S Bolis; I Casaroli; E Lanzi; E M Pogliani; G Corneo
Journal:  Support Care Cancer       Date:  1994-07       Impact factor: 3.603

9.  Association of serum soluble triggering receptor expressed on myeloid cells levels in malignant febrile neutropenic patients with bacteremia and fungemia.

Authors:  Mohammad-Taghi Arzanian; Babak Soltani; Alireza Fahimzad; Farideh Shiva; Ahmad-Reza Shamshiri; Abdollah Karimi
Journal:  Iran J Pediatr       Date:  2011-09       Impact factor: 0.364
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.